Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects

Publisher: John Wiley & Sons Inc

E-ISSN: 2047-9980|4|10|JAHA.115.001991-JAHA.115.001991

ISSN: 2047-9980

Source: JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol.4, Iss.10, 2015-10, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content